Tonix Pharmaceuticals Holding Corp. (TNXP) NASDAQ

31.21

+4.22(+15.64%)

Updated at September 11 04:00PM

Currency In USD

Valuation

Market Cap74.65M
Enterprise Value-16.01M
P/E Ratio-4.3
PEG Ratio-0.04
Price/Sales Ratio27.83
Price/Book Ratio1.36
Enterprise/Revenue15.13
Enterprise/EBITDA-1.84

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-5.41
Operating Margin-8.38

Management Effectiveness

Return On Assets-0.28
Return On Equity-0.38

Income Statement

Revenue10.09M
Revenue/Share1.34
Gross Profit2.33M
EBITDA-126.62M
Net Income-130.04M
Diluted EPS-176.6

Balance Sheet

Total Cash125.33M
Total Cash/Share17.1
Total Debt492,000
Total Debt/Equity0
Current Ratio7.53
Book Value Per Share22.93

Price History

52-Week Change95.43
52-Week High130
52-Week Low6.76
Moving Average 50 Days39.97
Moving Average 200 Days28.24

Statistics

Average Volume1.42M
Shares Outstanding8.77M
% Held by Institutions18.39

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:100
Last Split DateFebruary 05, 2025